The scientific usage of ketamine is rapidly increasing, underscoring the necessity for standardized guidelines to direct its use. This is especially critical given that ketamine use for TRD is at present not approved with the FDA despite a big human body of proof supporting its efficacy and protection. At this time, the long-expression threats and